Mr Mrs Miss Ms Dr Other

Dr
Robert
Scanes

Senior Patent Attorney

London Office

Chemistry

Telephone. +44(0) 207 776 5100
Email. rscanes@hgf.com

Experience

Robert specialises in patents and related IP rights in the fields of chemistry, pharmaceuticals and biotechnology.

He has broad experience in patent practice, including urgent drafting for SARS-CoV-2 antivirals during the COVID-19 pandemic, coordinating global patent portfolios for a pharmaceutical candidate in phase III clinical trials and contentious proceedings before the European Patent Office defending market exclusivity determining patents for authorised drugs. Robert also provides advice regarding freedom-to-operate and validity.

He is familiar with the differing needs of prosecuting applications in several fields, encompassing consumer goods, graphene technology and polymer chemistry.

Robert's technical experience spans the interface between chemistry and biology, working on new chemical entity, polymorphic form, dosage regimen and subsequent medical use cases.

Before joining the profession Robert discovered a new oscillating chemical reaction during his doctoral research, work that was highlighted in the journal Science. His laboratory work reflected his long-held interests in enantioselective catalysis, non-linear reaction kinetics, protocell movement, oligonucleotide modification and super-resolution microscopy. He holds a first class Master's degree in Natural Sciences from the University of Cambridge, where he was awarded scholarships and bursaries for academic performance.

Qualifications

Patent Attorney

Chartered (UK)
Europe


BA

BA in Natural Sciences, First Class, University of Cambridge

MSCI

Natural Sciences, First Class, University of Cambridge

POSTGRADUATE DIPLOMA OR CERTIFICATE

Intellectual Property Law, Distinction, Queen Mary University of London

OTHER

DPhil in Organic Chemistry, Thesis Title "Selection among Replicators and Protocell Chemotaxis", University of Oxford

Publications

EPO v UPC: How the EPO’s and UPC’s approaches to validity give us food for thought when drafting and prosecuting patent applications destined for Europe (Part 4)

View publication online

EPO v UPC: How the EPO’s and UPC’s approaches to validity give us food for thought when drafting and prosecuting patent applications destined for Europe (Part 3)

View publication online

EPO v UPC: How the EPO’s and UPC’s approaches to validity give us food for thought when drafting and prosecuting patent applications destined for Europe (Part 2)

View publication online

EPO v UPC: How the EPO’s and UPC’s approaches to validity give us food for thought when drafting and prosecuting patent applications destined for Europe (Part 1)

View publication online

UPC delivers first judgment on Validity and Infringement of a Second Medical Use Claim

View publication online

T 0295/22: Apremilast decision highlights hopes and challenges for broad second medical use claims

View publication online

T 1418/22: Acalabrutinib provides guidance on establishing inventiveness of polymorphs at the EPO

View publication online

Related News

Event - 27th October 2026

HGF sponsors pro-manchester Retail Lunch 2026

HGF is delighted to be sponsoring pro-manchester Retail Lunch 2026, taking place on Tuesday 27 October 2026 at INNSiDE by Meliá in Manchester. As part of the event, HGF Partner …

Event details
HGF

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article
HGF

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article
Event - 12th November 2026

HGF Partners with PPTI for 'Designing Foods for Healthy Aging' Webinar

As healthy aging, metabolic health and weight management rise up the consumer agenda, food and nutrition businesses are increasingly looking beyond traditional product development and towards solutions that deliver measurable …

Event details

Basel Seminar: Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU

Venue – Der Teufelhof Basel, Switzerland We are pleased to invite you to our seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU. …

Read article
Event - 28th October 2026

HGF Attending BMCS Antibody–Drug Conjugates 2026

HGF is pleased to announce that Dr Thomas Lonsdale, Patent Director, will be attending the BMCS Antibody–Drug Conjugates 2026 meeting, taking place on 19 November 2026 at GSK, Stevenage, UK. …

Event details

Hsu Min Chung Recognised in IAM Global Leaders 2027

HGF is delighted to announce that Partner, Hsu Min Chung, has been recognised in the IAM Global Leaders 2027 guide, a prestigious ranking that highlights some of the world’s leading …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.